Holen Sie sich die Stockscreener-App
0.212
41.53%
-0.1506
Handel nachbörslich:
.21
-0.002
-0.94%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.3626
Offen:
$0.241
24-Stunden-Volumen:
543.28K
Relative Volume:
0.56
Marktkapitalisierung:
$887.84K
Einnahmen:
$7.33M
Nettoeinkommen (Verlust:
$-21.20M
KGV:
-0.2319
EPS:
-0.9143
Netto-Cashflow:
$-12.68M
1W Leistung:
-52.63%
1M Leistung:
-83.69%
6M Leistung:
-95.20%
1J Leistung:
-97.04%
1-Tages-Spanne:
$0.1867
$0.2599
1-Wochen-Bereich:
$0.1867
$0.4725
52-Wochen-Spanne:
$0.1867
$7.80
Prophase Labs Inc Stock (PRPH) Company Profile
Firmenname
Prophase Labs Inc
Sektor
Branche
Telefon
(215) 345-0919
Adresse
711 STEWART AVE, SUITE 200, NEW YORK, PA
Vergleichen Sie PRPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.212 | 1.52M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
617.15 | 233.21B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
235.57 | 167.12B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
714.55 | 56.44B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.81 | 41.84B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
244.29 | 40.96B | 15.90B | 1.28B | 2.21B | 7.2842 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-13 | Herabstufung | Dawson James | Buy → Neutral |
| 2021-01-20 | Eingeleitet | Dawson James | Buy |
Prophase Labs Inc Aktie (PRPH) Neueste Nachrichten
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
ProPhase Labs, Inc.(NasdaqCM: PRPH) dropped from S&P TMI Index - MarketScreener
How one lab swapped $3.3M of debt for shares, jolting its stock price - Stock Titan
MSN Money - MSN
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
ProPhase Labs faces Nasdaq delisting, plans appeal, OTC move - TipRanks
ProPhase Labs Received Notice of Delisting - TradingView — Track All Markets
PRPH Stock Price, Forecast & Analysis | PROPHASE LABS INC (NASDAQ:PRPH) - Chartmill
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN
ProPhase Labs FY 2024 Earnings Preview - MSN
ProPhase Labs (PRPH) Stock Price, Quote, News & History - Benzinga
ProPhase Labs Inc. (NASDAQ: PRPH)Share Price - intelligentinvestor.com.au
Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on March 15, 2023. - marketscreener.com
ProPhase Labs signs non-binding LOI for proposed reverse merger with ABL - MSN
ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025 - ts2.tech
ProPhase Labs jumps as it signs LOI for reverse merger with Advanced Biological Laboratories - MSN
ProPhase Labs Earnings Notes - Trefis
ProPhase Labs announces proposed reverse merger with ABL - MSN
ProPhase Labs trading halted, news pending - MSN
ProPhase Labs Announces Proposed Reverse Merger with ABL - TipRanks
ProPhase Labs and ABL announce reverse merger plans By Investing.com - Investing.com Nigeria
ProPhase Labs files replacement legal opinion with new counsel By Investing.com - Investing.com Nigeria
ProPhase Labs files replacement legal opinion with new counsel - Investing.com
PRPH: Reverse merger LOI, $50M receivables recovery, and BE-Smart test commercialization advance - TradingView — Track All Markets
ProPhase Labs announces LOI for reverse merger with Advanced Biological - Proactive financial news
Will ProPhase Labs Inc. stock outperform Nasdaq index2025 AllTime Highs & Weekly High Return Stock Opportunities - DonanımHaber
ProPhase Labs stock soars after announcing reverse merger with ABL By Investing.com - Investing.com Nigeria
ProPhase Labs (PRPH) Surges on Proposed Reverse Merger with ABL - GuruFocus
ProPhase Labs stock soars after announcing reverse merger with ABL - Investing.com
PRPH: Proposed reverse merger gives ABL majority control and delivers near-term value to shareholders - TradingView — Track All Markets
ProPhase Labs, Advanced Biological Laboratories Sign Letter of Intent for Reverse Merger - marketscreener.com
ProPhase Labs, Inc. to Declare A Special Cash Dividend - marketscreener.com
What risks investors should watch in ProPhase Labs Inc. stockMarket Movement Recap & Capital Efficiency Focused Ideas - DonanımHaber
Why Is Prophase Labs Stock (PRPH) Up Today? - TipRanks
How ProPhase Labs Inc. stock compares to market leadersWeekly Risk Summary & Reliable Intraday Trade Plans - Улправда
Advanced Biological Laboratories S.A. signed a non-binding letter of intent to acquire ProPhase Labs, Inc. in a reverse merger transaction. - marketscreener.com
ProPhase Labs (PRPH) Explores Reverse Merger with ABL - GuruFocus
ProPhase Labs signs non-binding LOI for proposed reverse merger with Advanced Biological Laboratories - marketscreener.com
ProPhase’s proposed ABL merger could mean cash payout for holders - Stock Titan
Trading Recap: Is ProPhase Labs Inc. stock a safe haven assetQuarterly Portfolio Summary & Real-Time Chart Breakout Alerts - DonanımHaber
ABL Diagnostics Informs the Market of a Non‑Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger - Business Wire
ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories - Sahm
ProPhase Labs (NASDAQ: PRPH) sets 1-for-10 reverse stock split effective Dec. 22 - Stock Titan
Will ProPhase Labs Inc. stock remain a Wall Street favoriteWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - Улправда
Prophase Labs Faces Unsealed Civil Action Disclosure - MSN
Prophase Labs Implements Reverse Stock Split - The Globe and Mail
ProPhase Labs Delays Q3 Filing Amid Reorganization - MSN
ProPhase Labs (NASDAQ: PRPH) completes 1-for-10 reverse stock split, 5.77M shares outstanding - Stock Titan
Finanzdaten der Prophase Labs Inc-Aktie (PRPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.56%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):